ondansetron and Psychoses studies

ondansetron and Psychoses

ondansetron has been researched along with Psychoses in 4 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

Excerpt	Relevance	Reference
"This systematic review identified published studies that evaluated the use of ondansetron in individuals with psychosis associated with dementia."	8.98	Is ondansetron beneficial for psychosis associated with dementia?. ( Farheen, SA; Lingamchetty, T; Maksimowski, M; Tampi, RR, 2018)
"This systematic review identified published studies that evaluated the use of ondansetron in individuals with psychosis associated with dementia."	4.98	Is ondansetron beneficial for psychosis associated with dementia?. ( Farheen, SA; Lingamchetty, T; Maksimowski, M; Tampi, RR, 2018)
"Psychotic symptoms in Parkinson's disease (PD) are relatively common and, in addition to creating a disturbance in patients' daily lives, have consistently been shown to be associated with poor outcome."	2.44	Pathophysiology and treatment of psychosis in Parkinson's disease: a review. ( Fernandez, HH; Zahodne, LB, 2008)

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (50.00)

29.6817

2010's

2 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Kwan, C	1
Huot, P	1
Tampi, RR	1
Maksimowski, M	1
Lingamchetty, T	1
Farheen, SA	1
Zahodne, LB	1
Fernandez, HH	1
Rasimas, JJ	1

Studies

Kwan, C

Huot, P

Tampi, RR

Maksimowski, M

Lingamchetty, T

Farheen, SA

Zahodne, LB

Fernandez, HH

Rasimas, JJ

Reviews

2 reviews available for ondansetron and Psychoses

Article	Year
Is ondansetron beneficial for psychosis associated with dementia?. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2018, Volume: 30, Issue:3 Topics: Antipsychotic Agents; Cognition Disorders; Dementia; Humans; Ondansetron; Parkinson Disease; Psychot	2018
Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs & aging, 2008, Volume: 25, Issue:8 Topics: Antidepressive Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; El	2008

Article

Year

Is ondansetron beneficial for psychosis associated with dementia?.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2018, Volume: 30, Issue:3

Topics: Antipsychotic Agents; Cognition Disorders; Dementia; Humans; Ondansetron; Parkinson Disease; Psychot

2018

Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Drugs & aging, 2008, Volume: 25, Issue:8

Topics: Antidepressive Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; El

2008

Other Studies

2 other studies available for ondansetron and Psychoses

Article	Year
5-HT Neurodegenerative disease management, 2019, Volume: 9, Issue:5 Topics: Antipsychotic Agents; Humans; Ondansetron; Parkinson Disease; Psychotic Disorders; Receptors, Seroto	2019
Treatment of psychosis in Lewy body disease. The American journal of psychiatry, 2008, Volume: 165, Issue:2 Topics: Comorbidity; Electroconvulsive Therapy; Humans; Lewy Body Disease; Ondansetron; Parkinson Disease; P	2008

Article

Year

5-HT

Neurodegenerative disease management, 2019, Volume: 9, Issue:5

Topics: Antipsychotic Agents; Humans; Ondansetron; Parkinson Disease; Psychotic Disorders; Receptors, Seroto

2019

Treatment of psychosis in Lewy body disease.

The American journal of psychiatry, 2008, Volume: 165, Issue:2

Topics: Comorbidity; Electroconvulsive Therapy; Humans; Lewy Body Disease; Ondansetron; Parkinson Disease; P

2008